CXHL2100011 | 阿利沙坦酯吲达帕胺缓释片 | allisartan isoproxil;indapamide | Tablet, extended release | Chemical Drugs(2.3) | New Drug Application | 2021-01-09 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | In Review | 2021-01-08 | view |
CYHB2007105 | 阿利沙坦酯片 | allisartan isoproxil | Tablet | Chemical Drugs | Supplementary Application | 2020-09-22 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2020-12-21 | view |
CYHB2007104 | 阿利沙坦酯片 | allisartan isoproxil | Tablet | Chemical Drugs | Supplementary Application | 2020-09-22 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2020-12-21 | view |
CXHL2000533 | 阿利沙坦酯氨氯地平片 | allisartan isoproxil;amlodipine | Tablet | Chemical Drugs(2.3) | New Drug Application | 2020-10-20 | 深圳信立泰药业股份有限公司 | Shenzhen Salubris Pharmaceuticals Co Ltd | In Review | 2020-10-20 | view |
CXHB1200122 | 阿利沙坦酯 | allisartan isoproxil | Active ingredient | Chemical Drugs | Supplementary Application | 2013-02-25 | 江苏艾力斯生物医药有限公司 | Jiangsu Allist Pharmaceutical Co Ltd | Certificate Issued | 2013-10-17 | view |
CXHS1000100 | 艾力沙坦酯 | allisartan isoproxil | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2010-05-07 | 上海艾力斯医药科技有限公司;深圳信立泰药业股份有限公司 | Allist Pharmaceuticals Inc; Shenzhen Salubris Pharmaceuticals Co Ltd | Certificate Issued | 2012-07-17 | view |
CXHL0700150 | 艾力沙坦酯 | allisartan isoproxil | Active ingredient | Chemical Drugs(1.1) | New Drug Application | 2007-06-13 | 上海艾力斯医药科技有限公司 | Shanghai Allist Pharmaceuticals Co Ltd | Certificate Issued | 2007-12-26 | view |
CXHS2300079 | 阿利沙坦酯吲达帕胺缓释片 | allisartan isoproxil;indapamide | Tablet, extended release | Chemical Drugs(2.3) | New Drug Application | 2023-09-12 | | Shenzhen Salubris Pharmaceuticals Co Ltd | | | view |
CXHS2200061 | 阿利沙坦酯氨氯地平片 | allisartan isoproxil;amlodipine | Tablet | Chemical Drugs(2.3) | New Drug Application | 2022-11-03 | | Shenzhen Salubris Pharmaceuticals Co Ltd | | | view |
CXHL2101031 | 阿利沙坦酯吲达帕胺缓释片 | allisartan isoproxil;indapamide | Tablet, extended release | Chemical Drugs(2.3) | New Drug Application | 2021-04-15 | | Shenzhen Salubris Pharmaceuticals Co Ltd | | | view |